1. Reliability of the INSTI® rapid test for the diagnosis of HIV-1 non-B subtypes and recombinant variants
- Author
-
Aurélie Guigon, Laurent Bélec, Anne Languille, Thierry Prazuck, Laurent Hocqueloux, G. Giraudeau, Jeanne Goupil de Bouillé, David Plainchamp, Gwenaël Le Moal, and Aurelie Theillay
- Subjects
0301 basic medicine ,biology ,business.industry ,Human immunodeficiency virus (HIV) ,virus diseases ,Test sensitivity ,medicine.disease_cause ,Hiv subtype ,030112 virology ,Virology ,Test (assessment) ,law.invention ,03 medical and health sciences ,Infectious Diseases ,law ,Immunology ,medicine ,Recombinant DNA ,biology.protein ,Antibody ,business - Abstract
Data regarding the efficacy of Rapid HIV tests (RHTs) in detecting non-B subtype HIV-1 are limited. We evaluated the sensitivity of the INSTI® test for the detection of HIV-1 antibodies for the diagnosis of HIV-1 non-B subtypes and recombinant variants. We identified adults with HIV-1 infection due to non-B subtypes and recombinant variants. The participants were re-tested with INSTI® test. We included 258 patients. Overall, the INSTI® test sensitivity was 98.4% (95%CI: 96.9–99.9%). For the major CRF_02AG subtype, the sensitivity was 99.0% (95%CI: 97.1–100%). The HIV INSTI® test is reliable for the detection of various non-B HIV-1 antibodies. J. Med. Virol. 88:180–183, 2016. © 2015 Wiley Periodicals, Inc.
- Published
- 2015